Dietary Impact on Urinary pH in Women With Interstitial Cystitis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03041194 |
Recruitment Status :
Completed
First Posted : February 2, 2017
Last Update Posted : September 25, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Interstitial Cystitis | Other: dietary affects |
Study Type : | Observational |
Actual Enrollment : | 17 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Title A Pilot Study to Evaluate the Dietary Impact on Urinary pH in Interstitial Cystitis Pilot Study to Evaluate the Dietary Impact on Urinary pH in Interstitial Cystitis |
Actual Study Start Date : | January 2015 |
Actual Primary Completion Date : | December 2015 |
Actual Study Completion Date : | December 2015 |

- Other: dietary affects
Dietary affects on urine pH in relation to Interstitial cystitis symptoms
- The impact of urinary pH [ Time Frame: 1 year ]urinary pH.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Women, diagnosed with Interstitial Cystitis or with a presumptive clinical diagnosis of IC
- New IC patients who agree to hydrodistention and cystoscopy, the standard of care for diagnosis of IC
Exclusion Criteria:
- Subjects who are diagnosed with Fibromyalgia Syndrome and subjects that are pregnant.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03041194
Principal Investigator: | Rosemary Catanzaro, MS RD | St. Louis University |
Responsible Party: | Rosemary Catanzaro, RD, Principal Investigator, St. Louis University |
ClinicalTrials.gov Identifier: | NCT03041194 |
Other Study ID Numbers: |
25300 |
First Posted: | February 2, 2017 Key Record Dates |
Last Update Posted: | September 25, 2017 |
Last Verified: | September 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Cystitis Cystitis, Interstitial Urinary Bladder Diseases Urologic Diseases |